scispace - formally typeset
J

Joseph V. Uri

Researcher at Smith, Kline & French

Publications -  21
Citations -  294

Joseph V. Uri is an academic researcher from Smith, Kline & French. The author has contributed to research in topics: Cefazolin & Cephalosporin. The author has an hindex of 11, co-authored 21 publications receiving 279 citations.

Papers
More filters
Journal ArticleDOI

SK&F 75073, New Parenteral Broad-Spectrum Cephalosporin with High and Prolonged Serum Levels

TL;DR: Parenteral administration of SK&F 75073 to experimental animals resulted in high and prolonged serum levels when compared with cefazolin and other injectable cephalosporins, and this favorable serum profile was reflected in the excellent protection observed in mice infected with pathogenic bacteria.
Journal ArticleDOI

A new parenteral cephalosporin. sk&f 59962: 7-trifluoromethylthioacetamido-3-(1-methyl-1h-tetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid. chemistry and structure activity relationships

TL;DR: The synthesis, microbiological profile and in vivo effectiveness in laboratory animals of a series of cephalosporins having 7-acyl substituents derived from methylthioacetic acid are described, and one derivative, 7-trifluoromethylthioacetamido-3-cephem-4-carboxylic acid, was found to have outstanding antibacterial activity in vitro and in vitro.
Journal ArticleDOI

Orally active 7-phenylglycyl cephalosporins--Structure-activity studies related to cefatrizine(SK&F 60771)

TL;DR: One derivative, 7-[R-2-amino-2-(4-hydroxyphenylglycyl)acetamido]-3-triazole-4(5)-ylthiomethyl)-3-cephem-4-carboxylic acid was found to have outstanding in vitro and in vivo activities along with oral and subcutaneous serum levels in the mouse that were significantly higher than those obtained with cephalexin.
Journal ArticleDOI

Colorimetric detection and spectrophotometric determination of the aminothiazolyl-alkoxyimino .BETA.-lactams.

TL;DR: The 2-aminothiazolyl-4-yl-2-alkoxyiminoacetamido substituent-containing beta-lactam antibiotics develop a stable, concentration-dependent purple or cherry-red color after reaction with sodium nitrite in acidic condition.
Journal ArticleDOI

Laboratory studies with cefatrizine (SK + F 60771), a new broad-spectrum orally-active cephalosporin.

TL;DR: Cefatrizine had striking in vivo protective activity in mice infected with Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Hemophilus influenzae, Proteus morganii or Staphylococcus aureus reflecting its superior pharmacokinetic profile in this animal species.